Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Beiersdorf Study On Body Odor Spurs Work On Ethnically Sensitive Deodorants

This article was originally published in The Rose Sheet

Executive Summary

Findings from a recent study on the metabolic causes of body odor could pave the way for the development of deodorants that address the needs of specific ethnic populations, German consumer products firm Beiersdorf reports

You may also be interested in...



Beiersdorf R&D Tackles Problems Of Sweaty Teens, Under-Applied Sunscreen

Beiersdorf's research and development program is turning out solutions to some interesting skin-care and hygiene challenges, including "emotional" sweating in teens and a lack of proper sunscreen application in the general population

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016680

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel